Skip to main content
Equibles

Sarina Tanimoto

ARS Pharmaceuticals, Inc. (SPRY)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Sarina Tanimoto

ARS Pharmaceuticals, Inc. reported in an 8-K filed November 8, 2022 that Sarina Tanimoto was appointed Chief Medical Officer, effective November 8, 2022. The proxy statement of ARS Pharmaceuticals, Inc. reports total compensation of $4,246,773 for Sarina Tanimoto in fiscal 2024, including a base salary of $501,698. Disclosed compensation is on record for 3 fiscal years.

“At the effective time of the Merger, the Company's board of directors (and its committees) and executive officers were reconstituted to include the following directors and executive officers”
ARS Pharmaceuticals, Inc. Form 8-K, filed November 8, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at ARS Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 ARS Pharmaceuticals, Inc. (SPRY) $501,698 $4,246,773
2023 ARS Pharmaceuticals, Inc. (SPRY) $473,300 $4,791,493
2022 ARS Pharmaceuticals, Inc. (SPRY) $70,893 $338,147

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.